US 12295362
Formulations and processes for CAR T cell drug products
granted A61KA61K40/11A61K40/31
Quick answer
US patent 12295362 (Formulations and processes for CAR T cell drug products) held by Allogene Therapeutics, Inc. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4211